Safe, Effective, and Personalized Allergy Care—Right from Home
WomanWell offers at home immunotherapy, a comprehensive allergy treatment program proven to be safe and effective.
- Convenient & Safe Home Allergy Shot Program
Freedom from Allergies, Right from Your Home
- Our Philosophy
A Safer, Smarter Approach to Allergy Treatment
Unlike traditional immunotherapy offered at allergy clinics requiring years of maintenance dosing, evidence shows our immunotherapy regimen significantly reduces symptoms in much less time and can be conveniently administered at home.
- Frequently asked questions
Your Questions, Answered
At Womanwell, we believe care should feel personal, simple, and empowering—not confusing or overwhelming
What is immunotherapy?
Immunotherapy, also called allergy injections or allergy shots are injections that contain small, gradually increasing amounts of allergens (like pollen, dust, pet dander, mold) to desensitize your immune system for long-term relief from your environmental allergies.
What are the goals of Immunotherapy?
Our ultimate goal with immunotherapy is to maintain your symptom control even after you finish the treatment program.
How long does it take for Immunotherapy to work and how long will I need them?
Our program requires at home injections every other day for at least 1 year. You should feel the benefits of immunotherapy after a few months. We will reevaluate your progress throughout the program and may recommend a second year of treatment.
Does Immunotherapy work?
Studies have shown that immunotherapy works for 85% of people. For those that immunotherapy works for, studies have shown our at home regimen offers a >45% reduction in symptoms and >40% reduction in medication use compared to placebo.
What are the potential side effects of Immunotherapy?
Allergy immunotherapy has been around for over 100 years and there is no evidence of long-term side effects. Potential side effects range from local injection site reactions (redness, swelling and itching) to very rare systemic reactions such as hives, wheezing and anaphylaxis. The first dose of each new vial will be given in office to ensure you tolerate it well. You will also be given an epinephrine pen prescription and safety training.
- Subcutaneous Immunotherapy
The Gold Standard for Allergy Treatment
Subcutaneous immunotherapy (SCIT), or allergy shots have been around for over 100 years. SCIT is the most studied form of allergy treatment and is typically covered by insurance.
SCIT requires more education and potential side effects but is the fastest and most reliable method for reducing allergy symptoms.
Subcutaneous Immunotherapy (SCIT)
- Injection
- Standard therapy
- Covered by most insurance
- Shorter course
- Every other day dosing
- Potential side effects and anaphylaxis
- Sublingual Immunotherapy
Gentle, Needle-Free Allergy Relief at Home
Sublingual immunotherapy (SLIT), or allergy drops, is less studied and is not covered by insurance. SLIT, however, is easy to administer and rarely has side effects.
We often recommend SLIT for kids or needle-phobic adults.
Sublingual Immunotherapy (SLIT)
- Drops
- Newer therapy
- Not covered by insurance
- Longer course
- Daily dosing
- Rare side effects
- Sublingual Immunotherapy (SLIT)
Common Questions About SLIT
Sublingual Immunotherapy (SLIT), also known as allergy drops, offers a needle-free, convenient way to treat allergies from home. It’s especially ideal for children or adults who prefer a simpler routine.
Does insurance pay for allergy drops?
No. Despite several published studies demonstrating the effectiveness and safety of SLIT, it does not have FDA approval and is therefore considered “experimental.”
How long will I be on sublingual drops?
It depends on how severe your symptoms are. Some patients require only a few months, while others may need several years of drops.
Can my child be put on allergy drops?
Absolutely. SLIT is popular for children because there are no needles or injections. Dr. Pasha limits SLIT to ages over 5 years old.
Immunotherapy for Allergies
Dr. Raza Pasha discusses allergy management and nasal surgery in this featured interview on Great Day Houston.
Evidence-Based Results
Multiple studies support the safety and effectiveness of home-based immunotherapy compared to traditional clinic-based care.
Summary
These studies compared home-based versus clinic-based immunotherapy regimens for allergic rhinitis and asthma.
The findings show that when administered correctly, home-based subcutaneous immunotherapy (SCIT) can offer similar improvements in symptoms and medication use as traditional in-office treatments. Importantly, adherence and convenience were better in home-based programs, which suggests many patients may prefer this option. Ultimately, the right treatment approach depends on individual suitability, consistent administration, and proper medical guidance.
- Malling HJ, Weeke B. Allergy. 1987
A comparison of rush immunotherapy schedules for pollen induced rhinitis and asthma.
Compared home-based vs. clinic-based rush immunotherapy. Both showed similar improvements in symptoms and medication use, confirming home treatment can be equally effective.
- Hirsch SR, Frank P, Svehla K, Colombo G. Annals of Allergy. 1978
Home and clinic-based immunotherapy for tree pollen hay fever.
Found both home-based and clinic-based SCIT effective, with home-based patients reporting greater satisfaction due to convenience.
- Nelson HS, Ikle D, Buchmeier A, et al. Annals of Allergy, Asthma & Immunology. 2012
Comparison of efficacy, safety, and compliance of 2 different subcutaneous immunotherapy dosing regimens for cedar pollinosis.
Both clinic and home-based SCIT showed strong results. Compliance was higher among home-based patients, confirming its safety and practicality.
- Int Forum Allergy Rhinol. 2015 Oct 14
The efficacy assessment of a self‐administered immunotherapy protocol
These efficacy results, and our previous safety results, show that a carefully designed and implemented self‐administered SCIT protocol is efficacious and safe.
- Int Forum Allergy Rhinol. Author manuscript; available in PMC: 2016 Jan 31
The safety of self-administered allergen immunotherapy during the buildup and maintenance phases
Compared safety of home-based vs. clinic immunotherapy and found self administered immunotherapy performed at home to be safer and result in less systemic reactions than in clinic immunotherapy.
